Primary central nervous system erythroid sarcoma with <scp>NFIA‐CBFA2T3</scp> translocation: A rare but distinct clinicopathologic entity

Yevgeniy Linnik(Vanderbilt University Medical Center), Emily F. Mason(Vanderbilt University Medical Center), Devang Pastakia(Monroe Carell Jr. Children's Hospital), Ian L. Dryden(University of South Carolina), David R. Head(University of Southern California)
American Journal of Hematology
July 22, 2020
10.1002/ajh.25944
Cited by 12

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|786
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1991|722